BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Hanif H, Ali MJ, Susheela AT, Khan IW, Luna-Cuadros MA, Khan MM, Lau DTY. Update on the applications and limitations of alpha-fetoprotein for hepatocellular carcinoma. World J Gastroenterol 2022; 28(2): 216-229 [PMID: 35110946 DOI: 10.3748/wjg.v28.i2.216]
URL: https://www.wjgnet.com/1948-5182/full/v28/i2/216.htm
Number Citing Articles
Pengfei Ren, Keyan Wang, Jie Ma, Xiaoqin Cao, Jiuzhou Zhao, Chengzhi Zhao, Yongjun Guo, Hua Ye. Autoantibody Against Ferritin Light Chain is a Serum Biomarker for the Detection of Liver Cirrhosis but Not Liver CancerJournal of Hepatocellular Carcinoma 2022; : 221 doi: 10.2147/JHC.S352057
Peng Fu, Binbin Gong, Huiming Li, Qing Luo, Zikun Huang, Renfeng Shan, Junming Li, Shaoying Yan. Combined identification of three lncRNAs in serum as effective diagnostic and prognostic biomarkers for hepatitis B virus‐related hepatocellular carcinoma International Journal of Cancer 2022;  doi: 10.1002/ijc.34201
Daniel Rusie, Adriana Mercan Stanciu, Letitia Toma, Elena Laura Iliescu. Correlation Between Serum Alpha-Fetoprotein and Tumour Size in Patients With Hepatocellular Carcinoma Treated With Direct-Acting AntiviralsCureus 2022;  doi: 10.7759/cureus.24506